ND Biosciences closed a funding round (amount undisclosed) in Oct 2022. The company is based in Epalinges, Switzerland. Investors in the round: Biopôle Start-up Fund. Data as of 23 Sept 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
